New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...
Researchers at the University of Minnesota Twin Cities have developed a new 3D-printing method for creating realistic human ...
The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant ...
The institute has built more than 20 types of organs-on-chips, or miniature models of human organs lined with living cells, ...
An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...
Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.
Organoids are three-dimensional, self-organizing structures derived from stem cells that faithfully mimic the complexity of ...
When the human body gets hurt, most tissues heal—skin closes over a wound, bone heals itself. But not all organs heal that ...
The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...
Morning Overview on MSN
3D bioelectronic colon brings new accuracy to cancer research
Researchers have developed a miniature 3D human colon model that mimics lifelike functions to enhance precision in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback